98
Participants
Start Date
November 30, 2026
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
Naloxone 2 MG
The intervention consists of naloxone 2mg (2ml of 1mg/ml solution) administered by EMS personnel via the IV or IO route. The study intervention will be administered immediately (within 5 minutes) following the first dose of epinephrine. When naloxone hydrochloride is administered intravenously, the onset of action is generally apparent within two minutes. The naloxone will be administered following the first dose of epinephrine. The control is saline 2ml will be supplied in pre-filled syringes within numbered trial treatment packs. They will be identical in appearance to the naloxone syringes.
Saline 2ml
Placebo
University of California, San Francisco, San Francisco
University of California, San Francisco
OTHER